Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 23, 2018

DrugPatentWatch Database Preview

Amring Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AMRING PHARMS, and what generic and branded alternatives to AMRING PHARMS drugs are available?

AMRING PHARMS has six approved drugs.

Summary for Amring Pharms

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	6

Drugs and US Patents for Amring Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amring Pharms	LATANOPROST	latanoprost	SOLUTION/DROPS;OPHTHALMIC	200925-001	Mar 22, 2011	AT	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Amring Pharms	CIPROFLOXACIN HYDROCHLORIDE	ciprofloxacin hydrochloride	SOLUTION/DROPS;OPHTHALMIC	078598-001	Jan 16, 2008		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Amring Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OTIC	065216-001	Oct 31, 2005	AT	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Amring Pharms	BROMFENAC SODIUM	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	202030-001	Jan 9, 2013	AT1	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Amring Pharms

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey

Harvard Business School

Chinese Patent Office

Teva

UBS

Baxter

QuintilesIMS

Citi

Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.